Rationale: The influence of the lung bacterial microbiome, including potential pathogens, in patients with influenza-associated pulmonary aspergillosis (IAPA) or coronavirus disease (COVID-19)–asso…
Experts Jacky Smith MD Lorcan McGarvey Woo-Jung Song MD
Rationale: Clinical trials show that lumacaftor/ivacaftor (LUM/IVA) treatment has the potential to modify early cystic fibrosis (CF) disease progression in children as young as 2…
Rationale: The influence of the lung bacterial microbiome, including potential pathogens, in patients with influenza-associated pulmonary aspergillosis (IAPA) or coronavirus disease (COVID-19)–asso…
The human lung is a complex organ that comprises diverse populations of epithelial, mesenchymal, vascular, and immune cells, which gains even greater complexity during disease…
PHILADELPHIA — In addition to COPD, patients frequently have other chronic diseases on top of their lung disease, including type 2 diabetes and osteoporosis, according…
BOSTON — To help patients with interstitial lung disease lower the chances of having a sick baby, physicians must have “honest and accurate conversations” with…
Rationale: The influence of the lung bacterial microbiome, including potential pathogens, in patients with influenza-associated pulmonary aspergillosis (IAPA) or coronavirus disease (COVID-19)–asso…
CHEST is deeply involved in tobacco use, control, cessation, and regulation, and includes it as one of its priorities within advocacy.
More than 80 percent of former or current smokers have never heard of nor discussed LCS with a clinician
“What we know is a drop, what we don’t know is an ocean.” There are few areas in medicine where the famous quote from Sir…
